Naturhouse Health Sa · BME:NTH

Naturhouse Health Sa — FY2017 Earnings Presentation

12 slides from Naturhouse Health Sa's earnings presentation, Feb 23, 2018

  1. Slide 1: 2017 Results

    2017 Results 23 February 2017

  2. Slide 2: Disclaimer

    Disclaimer This document has been prepared by NATURHOUSE HEALTH S.A. (“NATURHOUSE” or the “Company”) for its exclusive use during the presentations announcing the Company’s results of 2017. NATURHOUSE does not authorise its dissemination, publication or use by any other person, whether physical or l

  3. Slide 3: Index

    Index  Main Figures  Consolidated Profit & Loss Account  Sales and EBITDA by Country  Naturhouse Centres  Net Cash & Dividends  Consolidated Balance Sheet  Strategy & Outlook  Price Sensitive Information Notes for the Period 3

  4. Slide 4: Main Figures

    Main Figures We have proposed(1) the final dividend payment for 2017 of €0.12/share to be paid on 7 May 2018, leading to a total dividend for 2017 of €0.32/share and reaching a payout of 96.7% and a per-dividend yield of 7.92%(2). Our 2017 payout and EBITDA margin commitments have been met. EBITDA m

  5. Slide 5: Consolidated Profit & Loss Account

    Consolidated Profit & Loss Account 2016 2017 Growth (%) Total Sales 97,815 94,700 -3.2% Procurements -28,638 -27,120 -5.3% Gross profit 69,177 67,580 -2.3% Gross profit margin 70.7% 71.4% Personnel -19,268 -20,390 5.8% Other operating expenses -17,764 -18,644 5.0% Other Income 477 746 56.4% EBITDA 3

  6. Slide 6: Sales & EBITDA by Country

    Sales & EBITDA by Country Sales according to country Turnover at the end of 2017 stood at €94.7m, highlighting the positive performance of the domestic 2016 2017 Growth (%) market, which has grown for the second year running. France 41,074 40,875 -0.5% Spain 19,181 19,343 0.8% Poland is still affec

  7. Slide 7: Naturhouse Centres

    Naturhouse Centres 2,360 centres, a new record. +33 countries, after launching in Ireland in September under the master franchise model. 81 net openings at the end of 2017. We did not achieve the forecast amount due to the provisional situation in Poland, but all other countries grew at the previous

  8. Slide 8: Net Cash Position & Dividends

    Net Cash Position & Dividends We continue to generate high levels of net cash, thus guaranteeing one of the most attractive dividends on the Spanish Stock Exchange Net cash position * Dividends 15.087 14.940 12.814 25.675 10.880 22.800 7.338 16.950 14.050 5.191 11.600 8.100 2012 2013 2014 2015 2016

  9. Slide 9: Balance Sheet

    Balance Sheet 2016 2017 Intangible assets 1,897 1,687 Property, plant & equipment 4,869 5,035 Non current financial assets 992 1,038 Investment in associated companies 3,208 3,136 Deferred tax assets 272 324 Non current Assets 11,238 11,220 Inventories 4,231 4,449 Trade receivables 4,806 4,373 Curre

  10. Slide 10: Strategy and Outlook

    Strategy and Outlook Our main goal is to continue to create value for our shareholders and remain at the forefront of the Spanish Stock Exchange in terms of dividend policy  Focus on growth France, Italy and Poland: a focus on increasing franchise numbers and the average per-customer spend. Conti

  11. Slide 11: Material Facts for the period

    Material Facts for the period Material facts for the period  18 January 2017: Net openings for 2016  27 February 2017: Final dividend for 2016  27 February 2017: 2016 results  27 February 2017: Annual Corporate Governance Report  27 February 2017: Annual Report on Director Remuneration  22 Mar

  12. Slide 12: CONTACT

    CONTACT María Pardo Martinez Investor Relations Manager Tel: +34 914323953 Email: accionista@naturhouse.com 12

Naturhouse Health — FY2017 Earnings Presentation on 6ix